UnitedHealthcare Connecticut ADHD Treatment Coverage | Klarity Health

Last updated: July 4, 2026

If you have UnitedHealthcare (UHC) insurance in Connecticut and you or a family member is managing attention-deficit/hyperactivity disorder (ADHD), understanding your coverage can help you access care sooner. Your UHC plan may cover online ADHD treatment through telehealth, including evaluations, medication management, and ongoing follow-up appointments.

Check if your UnitedHealthcare plan may cover ADHD treatment in Connecticut →

Connecticut Mental Health Parity Law and Your ADHD Coverage

Connecticut General Statutes § 38a-514b requires health insurance plans regulated by the state to cover mental health and substance use disorder benefits at parity with medical and surgical benefits. ADHD is recognized as a mental health condition under this law. This means that if your UHC plan covers in-person ADHD care, it generally may not impose stricter limitations — such as higher cost-sharing, tighter visit limits, or more restrictive prior authorization requirements — on equivalent mental health services.

Connecticut also maintains telehealth parity requirements for health plans. Coverage of telehealth-delivered mental health services, including ADHD evaluation and medication management, may be required under the same terms as in-person care under qualifying UHC plans.

Important note: These parity protections apply to state-regulated fully insured plans. If your coverage is through a self-funded employer plan governed by ERISA, Connecticut state parity law does not apply directly — ERISA plans are governed by the federal Mental Health Parity and Addiction Equity Act (MHPAEA). Review your Summary Plan Description or contact your HR department to confirm how your plan is regulated.

Does UnitedHealthcare Cover ADHD Treatment in Connecticut?

UHC plans in Connecticut typically cover ADHD-related services as mental health benefits, which may include:

• Initial ADHD evaluation and diagnostic assessment
• Medication management appointments (follow-up visits)
• Prescription coverage for ADHD medications (subject to formulary and PA requirements)
• Telehealth ADHD care with licensed providers

Coverage details — including copays, deductibles, and prior authorization requirements — vary by plan. Patients should verify their benefits before booking an appointment.

UnitedHealthcare ADHD Medication Formulary in Connecticut

Stimulant Medications (Schedule II)

All stimulant ADHD medications are Schedule II controlled substances and typically require prior authorization (PA) regardless of tier placement under UHC plans. Quantity limits — commonly a 30-day supply per fill — apply to all Schedule II stimulants.

Generic stimulants (Tier 1–2, PA required):

• Amphetamine salts IR/XR (generic Adderall IR/XR)
• Methylphenidate IR/ER (generic Ritalin, generic Concerta)
• Dextroamphetamine (generic Dexedrine)
• Mixed amphetamine salts ER (generic Adderall XR)

These medications are typically placed at Tier 1 or Tier 2 on the UHC formulary, meaning lower cost-sharing — but prior authorization approval is still required before the pharmacy can fill them.

Brand stimulants (Tier 3–4, PA + step therapy):

• Vyvanse (lisdexamfetamine) — Tier 3–4; step therapy (generic stimulant trial typically required first)
• Concerta brand — Tier 3–4; step therapy
• Focalin XR (dexmethylphenidate ER) brand — Tier 3–4; PA required
• Mydayis (mixed amphetamine salts extended release) — Tier 4; PA + step therapy
• Adzenys XR-ODT (amphetamine ER oral disintegrating tablet) — Tier 3–4; PA required
• Jornay PM (methylphenidate ER, evening dose formulation) — Tier 3–4; PA + step therapy

Step therapy means UHC may require documentation that a generic stimulant was tried and was ineffective, caused side effects, or is medically contraindicated before approving a brand-name stimulant.

Non-Stimulant ADHD Medications

Atomoxetine (generic Strattera) — Tier 1–2, PA varies by plan: Atomoxetine is the generic form of Strattera and is typically preferred under UHC formularies. Brand Strattera may require step therapy through the generic.

Guanfacine ER (generic Intuniv) — Tier 1–2, no PA typically required: Generic guanfacine ER is generally accessible without PA and is commonly used as an adjunctive treatment or for patients who cannot tolerate stimulants.

Clonidine ER (generic Kapvay) — Tier 1–2, no PA typically required: Generic clonidine ER follows a similar low-tier, lower-barrier pattern and is an option for patients needing non-stimulant coverage.

Qelbree (viloxazine ER) — Tier 3–4, PA required: Qelbree is a newer non-stimulant approved for ADHD in children and adults. As a brand-only medication, it requires PA under most UHC plans and may require step therapy through a generic non-stimulant first.

UnitedHealthcare Plan Types in Connecticut

UHC offers several plan types in Connecticut. Your coverage structure depends on which plan type you are enrolled in:

• PPO / EPO plans: You can typically see any in-network provider — including telehealth providers — without a referral. Most UHC members on Klarity Health access care through PPO or EPO plans.
• HMO plans: You may need a referral from your primary care physician (PCP) before seeing a mental health specialist or telehealth ADHD provider. Confirm referral requirements with UHC before scheduling.
• Medicare Advantage (UHC AARP): Mental health coverage under Medicare Advantage is governed by CMS rules. Benefits may differ from commercial plans, and telehealth coverage rules vary by plan year and service area.
• Access Health CT plans: Plans purchased through Connecticut’s state exchange (Access Health CT) follow ACA essential health benefit requirements and must include mental health and substance use disorder coverage. Telehealth parity protections apply to these plans.

Prior Authorization Process for ADHD Medications Under UHC

To obtain PA for a stimulant or non-stimulant ADHD medication under UHC, your provider will typically need to submit:

• A confirmed ADHD diagnosis with supporting clinical documentation
• History of prior treatments tried and their outcomes (required for step therapy)
• Medical necessity documentation (symptom severity, impact on daily functioning)
• Prescribing provider’s NPI and credentials

Standard PA decisions are typically issued within 2–5 business days. Urgent or expedited requests may be processed within 72 hours. If PA is denied, you have the right to request an internal appeal and, if needed, an independent external review under Connecticut law.

What to Do If UHC Denies Your ADHD Medication or Claim

If UHC denies a prior authorization request or a claim for ADHD treatment or medication:

1. Request the denial in writing — UHC must provide the specific reason for the denial.
2. File an internal appeal — Submit a written appeal with supporting clinical documentation from your provider.
3. Request external review — If the internal appeal is upheld, you may request an independent external review under Connecticut law.
4. Contact the Connecticut Insurance Department (CID) — If you believe your mental health parity rights under CGS § 38a-514b have been violated, file a complaint with the CID at 1-800-203-3447 or visit portal.ct.gov/cid.

For ERISA self-funded plans, the external review and complaint escalation process follows federal rules rather than Connecticut state procedures.

How to Access ADHD Treatment Through Klarity Health

Klarity Health connects patients in Connecticut with 2,000+ licensed providers who specialize in ADHD evaluation and medication management via telehealth. Appointments are conducted entirely online — no commute, no waiting room. After evaluation, your provider can submit PA requests on your behalf and manage your prescription electronically.

Check if your UnitedHealthcare plan may cover ADHD treatment in Connecticut →

Frequently Asked Questions

Does UnitedHealthcare cover ADHD evaluations in Connecticut?

UHC plans in Connecticut may cover ADHD evaluations as a mental health benefit. Coverage, copay amount, and any referral requirements depend on your specific plan type. Patients should verify their benefits with UHC before booking.

Does UnitedHealthcare cover Adderall in Connecticut?

Generic amphetamine salts (Adderall generic) are typically placed at Tier 1–2 on UHC formularies and may be covered with prior authorization. PA is required for all Schedule II stimulants under UHC, including generic formulations. Brand-name Adderall is generally subject to step therapy requiring a generic trial first.

Does UnitedHealthcare cover Vyvanse in Connecticut?

Vyvanse is typically Tier 3–4 on UHC formularies and may require both PA and step therapy, meaning documentation that a generic stimulant was tried first. Coverage is plan-specific — verify your formulary through your UHC member portal or by calling the member services number on your insurance card.

Does UnitedHealthcare cover telehealth ADHD treatment in Connecticut?

Connecticut’s telehealth parity requirements may require that state-regulated health plans cover telehealth mental health services under the same terms as in-person care. Qualifying UHC plans may cover telehealth ADHD appointments with licensed providers. ERISA self-funded plans follow federal telehealth rules. Coverage varies by plan — verify before booking.

How long does UHC prior authorization for ADHD medication take in Connecticut?

Standard PA requests are typically processed within 2–5 business days. Urgent or expedited requests may be processed within 72 hours. Klarity Health providers can submit PA requests electronically and follow up with UHC on your behalf.

What if I have a UHC HMO plan in Connecticut?

HMO plans may require a referral from your primary care physician before accessing specialty mental health services, including telehealth ADHD care. Contact UHC or review your plan documents to confirm referral requirements for your specific plan before scheduling an appointment.

See if you may qualify for online ADHD treatment at Klarity Health →

Coverage information on this page reflects general UnitedHealthcare formulary and plan structure patterns and is provided for informational purposes only. Actual coverage, cost-sharing, and prior authorization requirements vary by plan. Patients should verify their specific benefits with UnitedHealthcare before booking an appointment. Coverage decisions are made by your insurance plan, not by Klarity Health.